Summary
The BRIC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market size (value , and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the pharmaceuticals industry and had a total market value of $2,37,909.5 million in 2024. Brazil was the fastest growing country with a CAGR of 6.8% over the 2020-24 period.
- Within the pharmaceuticals industry, China is the leading country among the BRIC nations with market revenues of $1,56,589.1 million in 2024. This was followed by India, Brazil and Russia with a value of $40,265.1, $27,129.2, and $13,926.1 million, respectively.
- China is expected to lead the pharmaceuticals industry in the BRIC nations with a value of $2,09,908.0 million in 2029, followed by India, Brazil, Russia with expected values of $53,016.9, $34,928.5 and $17,007.3 million, respectively.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the BRIC pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the BRIC pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players’ BRIC operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the BRIC pharmaceuticals market with five year forecasts
- Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country
Reasons to Buy
- What was the size of the BRIC pharmaceuticals market by value in 2024?
- What will be the size of the BRIC pharmaceuticals market in 2029?
- What factors are affecting the strength of competition in the BRIC pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up the BRIC pharmaceuticals market?
'
Table of Contents
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 BRIC Pharmaceuticals
2.1. Industry Outlook
3 Pharmaceuticals in Brazil
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Pharmaceuticals in China
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Pharmaceuticals in India
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Pharmaceuticals in Russia
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 Macroeconomic Indicators
10.1. Country data
11 Company Profiles
11.1. Johnson & Johnson
11.2. Merck & Co Inc
11.3. AbbVie Inc
11.4. Pfizer Inc
11.5. Sinopharm Group Co Ltd
11.6. Shanghai Pharmaceuticals Holding Co Ltd
11.7. CSPC Pharmaceutical Group Ltd
11.8. Takeda Pharmaceutical Co Ltd
11.9. Novartis AG
11.10. AstraZeneca Plc
11.11. GSK plc
11.12. F. Hoffmann-La Roche Ltd
11.13. Sanofi
11.14. Laboratoires Pierre Fabre SA
11.15. Les Laboratoires Servier SAS
11.16. Ipsen SA
11.17. Bayer AG
11.18. Boehringer Ingelheim International GmbH
11.19. Fresenius Medical Care AG & Co KGaA
11.20. Merck KGaA
11.21. CSL Ltd
11.22. Ramsay Health Care Ltd
11.23. Mayne Pharma Group Ltd
11.24. Ache Laboratorios Farmaceuticos SA
11.25. EMS SA
11.26. Hypera SA
11.27. Eurofarma Laboratorios SA
11.28. Apotex Inc
11.29. Bausch Health Companies Inc
11.30. Jiangsu Hengrui Pharmaceuticals Co Ltd
11.31. Sun Pharmaceutical Industries Ltd
11.32. Lupin Ltd
11.33. Cipla Ltd
11.34. Dr. Reddy's Laboratories Ltd
11.35. PT Kimia Farma Tbk
11.36. PT Kalbe Farma Tbk
11.37. PT Tempo Scan Pacific Tbk
11.38. A. Menarini Industrie Farmaceutiche Riunite Srl
11.39. Recordati SpA
11.40. Chiesi Farmaceutici SpA
11.41. Astellas Pharma Inc
11.42. Daiichi Sankyo Co Ltd
11.43. Otsuka Holdings Co Ltd
11.44. Genomma Lab Internacional SAB de CV
11.45. Pharmstandard
11.46. Binnopharm Group
11.47. OTC Pharma International BV
11.48. H. Lundbeck AS
11.49. Novo Nordisk AS
11.50. Aspen Pharmacare Holdings Ltd
11.51. Adcock Ingram Holdings Ltd
11.52. Chong Kun Dang Pharmaceutical Corp.
11.53. Hanmi Pharmaceuticals Co Ltd
11.54. Celltrion Inc
11.55. Yuhan Corp
11.56. Almirall SAS
11.57. Grifols SA
11.58. Laboratorios Farmaceuticos Rovi SA
11.59. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
11.60. Deva Holding AS
12 Appendix
12.1. Methodology
12.2. About MarketLine
List of Tables
Table 1: BRIC pharmaceuticals industry, revenue($m), 2020-29
Table 2: BRIC pharmaceuticals industry, revenue($m), 2020-24
Table 3: BRIC pharmaceuticals industry, revenue($m), 2024-29
Table 4: Brazil pharmaceuticals market value: $ million, 2019-24
Table 5: Brazil pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 6: Brazil pharmaceuticals market category segmentation: $ million, 2019-24
Table 7: Brazil pharmaceuticals market geography segmentation: $ million, 2024
Table 8: Brazil pharmaceuticals market value forecast: $ million, 2024-29
Table 9: Brazil Size of Population (Million), 2020-24
Table 10: Brazil Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 11: Brazil GDP (Current Prices, $ Billion), 2020-24
Table 12: Brazil Inflation, 2020-24
Table 13: Brazil Consumer Price Index (Absolute), 2020-24
Table 14: Brazil Exchange Rate, 2019-24
Table 15: China pharmaceuticals market value: $ million, 2019-24
Table 16: China pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 17: China pharmaceuticals market category segmentation: $ million, 2019-24
Table 18: China pharmaceuticals market geography segmentation: $ million, 2024
Table 19: China pharmaceuticals market value forecast: $ million, 2024-29
Table 20: China Size of Population (Million), 2020-24
Table 21: China Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 22: China GDP (Current Prices, $ Billion), 2020-24
Table 23: China Inflation, 2020-24
Table 24: China Consumer Price Index (Absolute), 2020-24
Table 25: China Exchange Rate, 2019-24
Table 26: India pharmaceuticals market value: $ million, 2019-24
Table 27: India pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 28: India pharmaceuticals market category segmentation: $ million, 2019-24
Table 29: India pharmaceuticals market geography segmentation: $ million, 2024
Table 30: India pharmaceuticals market value forecast: $ million, 2024-29
Table 31: India Size of Population (Million), 2020-24
Table 32: India Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 33: India GDP (Current Prices, $ Billion), 2020-24
Table 34: India Inflation, 2020-24
Table 35: India Consumer Price Index (Absolute), 2020-24
Table 36: India Exchange Rate, 2019-24
Table 37: Russia pharmaceuticals market value: $ million, 2019-24
Table 38: Russia pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 39: Russia pharmaceuticals market category segmentation: $ million, 2019-24
Table 40: Russia pharmaceuticals market geography segmentation: $ million, 2024
Table 41: Russia pharmaceuticals market value forecast: $ million, 2024-29
Table 42: Russia Size of Population (Million), 2020-24
Table 43: Russia Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 44: Russia GDP (Current Prices, $ Billion), 2020-24
Table 45: Russia Inflation, 2020-24
Table 46: Russia Consumer Price Index (Absolute), 2020-24
Table 47: Russia Exchange Rate, 2019-24
List of Figures
Figure 1: BRIC pharmaceuticals industry, revenue($m), 2020-29
Figure 2: BRIC pharmaceuticals industry, revenue($m), 2020-24
Figure 3: BRIC pharmaceuticals industry, revenue($m), 2024-29
Figure 4: Brazil pharmaceuticals market value: $ million, 2019-24
Figure 5: Brazil pharmaceuticals market category segmentation: $ million, 2019-24
Figure 6: Brazil pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 7: Brazil pharmaceuticals market value forecast: $ million, 2024-29
Figure 8: Forces driving competition in the pharmaceuticals market in Brazil, 2024
Figure 9: Drivers of buyer power in the pharmaceuticals market in Brazil, 2024
Figure 10: Drivers of supplier power in the pharmaceuticals market in Brazil, 2024
Figure 11: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2024
Figure 12: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2024
Figure 13: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2024
Figure 14: China pharmaceuticals market value: $ million, 2019-24
Figure 15: China pharmaceuticals market category segmentation: $ million, 2019-24
Figure 16: China pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 17: China pharmaceuticals market value forecast: $ million, 2024-29
Figure 18: Forces driving competition in the pharmaceuticals market in China, 2024
Figure 19: Drivers of buyer power in the pharmaceuticals market in China, 2024
Figure 20: Drivers of supplier power in the pharmaceuticals market in China, 2024
Figure 21: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2024
Figure 22: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2024
Figure 23: Drivers of degree of rivalry in the pharmaceuticals market in China, 2024
Figure 24: India pharmaceuticals market value: $ million, 2019-24
Figure 25: India pharmaceuticals market category segmentation: $ million, 2019-24
Figure 26: India pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 27: India pharmaceuticals market value forecast: $ million, 2024-29
Figure 28: Forces driving competition in the pharmaceuticals market in India, 2024
Figure 29: Drivers of buyer power in the pharmaceuticals market in India, 2024
Figure 30: Drivers of supplier power in the pharmaceuticals market in India, 2024
Figure 31: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2024
Figure 32: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2024
Figure 33: Drivers of degree of rivalry in the pharmaceuticals market in India, 2024
Figure 34: Russia pharmaceuticals market value: $ million, 2019-24
Figure 35: Russia pharmaceuticals market category segmentation: $ million, 2019-24
Figure 36: Russia pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 37: Russia pharmaceuticals market value forecast: $ million, 2024-29
Figure 38: Forces driving competition in the pharmaceuticals market in Russia, 2024
Figure 39: Drivers of buyer power in the pharmaceuticals market in Russia, 2024
Figure 40: Drivers of supplier power in the pharmaceuticals market in Russia, 2024
Figure 41: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2024
Figure 42: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2024
Figure 43: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2024
